Delayed occurrence of cytomegalovirus disease in organ transplant recipients receiving antiviral prophylaxis: are we winning the battle only to lose the war?

Eur J Clin Microbiol Infect Dis. 2002 Sep;21(9):643-6. doi: 10.1007/s10096-002-0801-6. Epub 2002 Sep 6.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiviral Agents / administration & dosage*
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / immunology
  • Cytomegalovirus Infections / prevention & control*
  • Female
  • Graft Rejection / prevention & control
  • Graft Survival
  • Humans
  • Male
  • Opportunistic Infections / drug therapy*
  • Opportunistic Infections / immunology
  • Opportunistic Infections / prevention & control*
  • Organ Transplantation / adverse effects
  • Organ Transplantation / methods
  • Primary Prevention / methods
  • Prognosis
  • Sensitivity and Specificity
  • Transplantation Immunology

Substances

  • Antiviral Agents